Xylem shareholders approve share issuance for Evoqua merger; closing awaits China clearance

Xylem Inc.

Shareholders voted 145.6M FOR, 585K AGAINST, 1.4M abstentions on share issuance proposal.
Merger with Evoqua remains subject to regulatory clearance from China.
Special meeting held May 11, 2023; quorum of 147.6M shares present.
Deal announced Jan 22, 2023; Xylem to issue shares to Evoqua stockholders.

item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Xylem Inc. shareholders approved Approval of Xylem Share Issuance Proposal at the 2023-05-11 meeting.

Proposal: merger approval
Outcome: passed
Meeting: 2023-05-11

Exact text from the filing

Xylem’s shareholders approved the proposal (the “Share Issuance Proposal”) to issue shares of Xylem Common Stock to Evoqua’s stockholders in connection with the Merger (as such term is defined in the Merger Agreement) pursuant to the terms of the Merger Agreement.

View on SEC.gov

Browse all shareholder votes →

Xylem Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-142138

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.